Signum Dermalogix's Grant

Signum Dermalogix raised a round of funding on November 15, 2013. Investors include National Institute of Arthritis and Musculoskeletal and Skin Diseases.

Signum Dermalogix, a spin out of Signum Biosciences is a private biotech company founded in 2011 from technologies developed by Dr. Jeffry Stock at Princeton University. The company has developed cosm…

Articles about Signum Dermalogix's Grant: